Close
Novotech
Jabsco PureFlo 21 Single Use

Kuehne+Nagel new airside facility boosts Africa’s healthcare logistics capability

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...
- Advertisement -

Kuehne+Nagel has entered into a long-term agreement for a new airside facility strategically located in the airport zone of OR Tambo International airport, Johannesburg, South Africa – the largest and busiest airport in Africa. As part of this agreement, Kuehne+Nagel offers customers a set of logistics solutions, including warehousing, transportation, customs brokerage, supply chain management, and airside support to project-specific charter in- and outbound shipments. Core to this offering is a comprehensive cold chain solution, ensuring around-the-clock temperature-control to safeguard the integrity of highly sensitive pharma products.

The new offering is pivotal to supporting Africa’s aim to become more self-reliant in healthcare operations. South Africa, Nigeria, and Algeria are leading the manufacturing charge in sub-Saharan Africa, while imports from Europe, North America, India and China remain crucial to meeting Africa’s demand for medicines and basic healthcare. To support its healthcare customers – both importers and manufacturers – in executing their strategic growth plans for Africa, Kuehne+Nagel’s new facility is designed with healthcare and pharmaceuticals in mind.

“Pharmaceuticals in particular are highly-sensitive, time-critical products,” says Gereon Niemeier, Managing Director, Kuehne+Nagel South Africa. “Every minute these products spend on the tarmac exposes them to temperature fluctuations, physical damage, and loss. Our new facility addresses all these challenges to ensure product stability throughout the journey.”

“Our people have the expertise for plane-side access that other logistics providers don’t,” Niemeier points out. “In addition, the facility is so close to the charter parking area that we can provide in-person visibility resources, as well as a unique dollie solution, that greatly reduce the risk of ground handling errors as well as shipment claims. On-site monitoring protects product stability — whether temperature-controlled, high value or time critical — throughout the entire journey.

Latest stories

Related stories

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...

Biomaterials and Local Drug Delivery in Implant Surgery

Advances in biomaterials and localized drug delivery systems are...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »